GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » Institutional Ownership

Edwards Lifesciences (LTS:0REN) Institutional Ownership : 53.11% (As of Jun. 04, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Edwards Lifesciences's institutional ownership is 53.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Edwards Lifesciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Edwards Lifesciences's Float Percentage Of Total Shares Outstanding is 99.14%.


Edwards Lifesciences Institutional Ownership Historical Data

The historical data trend for Edwards Lifesciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Institutional Ownership Chart

Edwards Lifesciences Historical Data

The historical data trend for Edwards Lifesciences can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 60.84 60.37 61.29 57.09 57.41 53.72 53.29 53.71 53.35 53.11

Edwards Lifesciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Edwards Lifesciences (LTS:0REN) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines